Beta Bionics, Inc. · NASDAQ:BBNX
Feider Stephen sold 382 Beta Bionics, Inc. shares (Form 4)
Traded Nov 5, 2026 · Filed Nov 9, 2026
On Nov 5, 2026, Feider Stephen (Chief Financial Officer) sold 382 Beta Bionics, Inc. shares at US$17.04 for US$6,508 under a trading plan, leaving 159,378 shares. Filed Nov 9, 2026 (Form 4).
- Sold
- 382 shares
- Price
- US$17.04
- Value
- US$6,508
- Holding after
- 159,378 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Common Stock | Option exercise | 382 | US$5.10 | 159,760 | Direct |
| Nov 5, 2026 | Common Stock | Sale | 382 | US$17.04 | 159,378 | Direct |
Source
Download original · View original at SEC
Related
- Beta Bionics, Inc.
- Feider Stephen
- Beta Bionics, Inc. shareholders
- Form 4 · Feider Stephen · Nov 13, 2026
- Form 4 · Feider Stephen · Nov 12, 2026
- Form 4 · Feider Stephen · Sep 3, 2026
- Form 4/A · Feider Stephen · Jul 2, 2026
- Form 4 · Feider Stephen · Jun 30, 2026
- Form 4 · Hopman Mark · Nov 18, 2026
- Schedule 13G/A · Divisadero Street Capital Management, LP · Nov 16, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Nov 16, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Nov 9, 2026
- Form 4 · Hopman Mark · Nov 4, 2026